Full Library

The COVID-19 pandemic has had a significant impact on donor evaluation and organ procurement.1 As the virus entrenches itself, the risk of donor-derived infection must be balanced with the risk of morbidity and mortality while remaining on the transplant waitlist. Decisions to proceed with organ transplant locally must balance the existing capacity of the center, availability of testing for donors and candidates, and sufficient capacity to provide adequate occupational protection to recovery and transplant staff.2 The recommendations in this document are based upon current peer-reviewed literature and public health data and represent a consensus opinion from TID Council, all of whom are practicing clinicians. Given that knowledge about SARS-CoV-2 continues to evolve, the recommendations contained in this document are subject to change. Additionally, the authors recognize that access to diagnostic assays may vary globally, particularly in resource-limited settings, and local approaches to donor evaluation may need to be adopted accordingly.